Agency Information Collection Activities; Proposed Collection; Comment Request; Control of Communicable Diseases; Restrictions on African Rodents, Prairie Dogs, and Certain Other Animals, 11368-11369 [E7-4450]

Download as PDF 11368 Federal Register / Vol. 72, No. 48 / Tuesday, March 13, 2007 / Notices of Dockets Management (see ADDRESSES) regarding this guidance document at any time. Submit a single copy of electronic comments or two paper copies of any mailed comments, except that individuals may submit one paper copy. Comments are to be identified with the docket number found in brackets in the heading of this document. The draft final guidance and received comments may be seen in the office above between 9 a.m. and 4 p.m., Monday through Friday. IV. Electronic Access Persons with access to the Internet may obtain the draft final guidance document at https://www.cfsan.fda.gov/ ~dms/guidance.html. Dated: March 5, 2007. Jeffrey Shuren, Assistant Commissioner for Policy. [FR Doc. E7–4446 Filed 3–12–07; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. 2007N–0073] Agency Information Collection Activities; Proposed Collection; Comment Request; Control of Communicable Diseases; Restrictions on African Rodents, Prairie Dogs, and Certain Other Animals AGENCY: Food and Drug Administration, HHS. cprice-sewell on PROD1PC66 with NOTICES ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing an opportunity for public comment on the proposed collection of certain information by the agency. Under the Paperwork Reduction Act of 1995 (the PRA), Federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on the information collection requirements establishing restrictions on the import, capture, transport, sale, barter, exchange, distribution, and release of African rodents, prairie dogs, and certain other animals. DATES: Submit written or electronic comments on the collection of information by May 14, 2007. ADDRESSES: Submit electronic comments on the collection of VerDate Aug<31>2005 14:58 Mar 12, 2007 Jkt 211001 information to: https://www.fda.gov/ dockets/ecomments. Submit written comments on the collection of information to the Division of Dockets Management (HFA–305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. All comments should be identified with the docket number found in brackets in the heading of this document. FOR FURTHER INFORMATION CONTACT: Jonna Capezzuto, Office of the Chief Information Officer (HFA–250), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857,301–827– 4659. Under the PRA (44 U.S.C. 3501–3520), Federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. ‘‘Collection of information’’ is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and includes agency requests or requirements that members of the public submit reports, keep records, or provide information to a third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A)) requires Federal agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, before submitting the collection to OMB for approval. To comply with this requirement, FDA is publishing notice of the proposed collection of information set forth in this document. With respect to the following collection of information, FDA invites comments on these topics: (1) Whether the proposed collection of information is necessary for the proper performance of FDA’s functions, including whether the information will have practical utility; (2) the accuracy of FDA’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques, when appropriate, and other forms of information technology. SUPPLEMENTARY INFORMATION: Control of Communicable Diseases; African Rodents and Other Animals That May Carry the Monkeypox Virus—21 CFR 1240.63 (OMB Control Number 0910–0519)—Extension Under 21 CFR 1240.63(a)(2)(ii), an individual must submit a written PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 request to seek permission to capture, offer to capture, transport, offer to transport, sell, barter, or exchange, offer to sell, barter, or exchange, distribute, offer to distribute, and/or release into the environment any of the following animals: • Prairie dogs (Cynomys sp.), • African Tree squirrels (Heliosciurus sp.), • Rope squirrels (Funisciurus sp.), • African Dormice (Graphiurus sp.), • Gambian giant pouched rats (Cricetomys sp.), • Brush-tailed porcupines (Atherurus sp.), • Striped mice (Hybomys sp.), or • Any other animal so prohibited by order of the Commissioner of Food and Drugs (the Commissioner) because of that animal’s potential to transmit the monkeypox virus. The request cannot seek written permission to sell, barter, or exchange, or offer to sell, barter, or exchange, as a pet, the animals listed previously or any animal covered by an order by the Commissioner. The request must state the reasons why an exemption is needed, describe the animals involved, and explain why an exemption will not result in the spread of monkeypox within the United States. Our estimates are based on our current experience with the interim final rule. To estimate the number of respondents, we examined the number of requests we have received in fiscal year 2006. There were 122 requests, submitted by 65 individuals, in that time, and this figure represents a minor increase over the previous estimate of 120 annual responses. (See 69 FR 7752 (February 19, 2004).) As we cannot determine whether the latest data indicates a trend towards more requests or is an anomaly, we have elected to increase our estimate to 122 requests. We also have revised the estimated number of respondents to 65 (compared to 120 in our previous estimate) and, as a result, adjusted the annual frequency per response to 1.88 (which represents 122 responses/65 respondents; the actual result is 1.8769, which we have rounded up to 1.88). Furthermore, consistent with our earlier Paperwork Reduction Act submission, we will estimate that each respondent will need 4 hours to complete its request for an exemption. Therefore, the total reporting burden under 21 CFR 1240.63(a)(2)(ii)(A) and (B) will be 488 hours (122 responses x 4 hours per response = 488 hours). FDA estimates the burden of this collection of information as follows: E:\FR\FM\13MRN1.SGM 13MRN1 11369 Federal Register / Vol. 72, No. 48 / Tuesday, March 13, 2007 / Notices ESTIMATED ANNUAL REPORTING BURDEN1 No. of Respondents 21 CFR Section 1240.63(a)(2)(ii)(A) and (B) 1 There Annual Frequency per Response 65 Total No. of Responses 1.88 122 Dated: March 6, 2007. Jeffrey Shuren, Assistant Commissioner for Policy. [FR Doc. E7–4454 Filed 3–12–07; 8:45 am] BILLING CODE 4160–01–S BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Food and Drug Administration [Docket No. 2004N–0257] [Docket No. 2006N–0130] Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Food Labeling; Trans Fatty Acids in Nutrition Labeling Food and Drug Administration, HHS. ACTION: 4 488 ACTION: The Food and Drug Administration (FDA) is announcing that a collection of information entitled ‘‘Food Labeling; Trans Fatty Acids in Nutrition Labeling’’ has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995. FOR FURTHER INFORMATION CONTACT: Jonna Capezzuto, Office of the Chief Information Officer (HFA–250), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857,301–827– 4659. In the Federal Register of October 12, 2006 (71 FR 60157), the agency announced that the proposed information collection had been submitted to OMB for review and clearance under 44 U.S.C. 3507. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910–0515. The approval expires on January 31, 2010. A copy of the supporting statement for this information collection is available on the Internet at https://www.fda.gov/ ohrms/dockets. SUPPLEMENTARY INFORMATION: VerDate Aug<31>2005 14:58 Mar 12, 2007 Food and Drug Administration, HHS. Notice. Jkt 211001 Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing that a collection of information entitled ‘‘Recordkeeping Requirements for Human Food and Cosmetics Manufactured From, Processed With, or Otherwise Containing, Material from Cattle’’ has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995. FOR FURTHER INFORMATION CONTACT: Jonna Capezzuto, Office of the Chief Information Officer (HFA–250), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857,301–827– 4659. In the Federal Register of October 11, 2006 (71 FR 59653), the agency announced that the proposed information collection had been submitted to OMB for review and clearance under 44 U.S.C. 3507. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910–0597. The approval expires on January 31, 2010. A copy of the supporting statement for this information collection is available on SUPPLEMENTARY INFORMATION: PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 the Internet at https://www.fda.gov/ ohrms/dockets. Dated: March 6, 2007. Jeffrey Shuren, Assistant Commissioner for Policy. [FR Doc. E7–4455 Filed 3–12–07; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Recordkeeping Requirements for Human Food and Cosmetics Manufactured From, Processed With, or Otherwise Containing, Material from Cattle AGENCY: SUMMARY: cprice-sewell on PROD1PC66 with NOTICES Total Hours are no capital costs or operating and maintenance costs associated with this collection of information. Dated: March 6, 2007. Jeffrey Shuren, Assistant Commissioner for Policy. [FR Doc. E7–4450 Filed 3–12–07; 8:45 am] AGENCY: Hours per Response [Docket No. 2007N–0069] Animal Drug User Fee Act; Public Meeting AGENCY: Food and Drug Administration, HHS. ACTION: Notice of public meeting. The Food and Drug Administration (FDA) is announcing a public meeting on the Animal Drug User Fee Act of 2003 (ADUFA) to seek public comments relative to the program’s overall performance and reauthorization as directed by Congress. Date and Time: The public meeting will be held on April 24, 2007, beginning at 9 a.m. Location: The public meeting will be held at the Food and Drug Administration, 7519 Standish Pl., third floor, rm. A, Rockville, MD 20855. There is parking near the building. Photo identification is required to clear building security. Contact: Aleta Sindelar, Office of the Director (HFV–3), Center for Veterinary Medicine, Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240–276–9004, FAX 240–276–9020, e-mail: aleta.sindelar@fda.hhs.gov. Registration and Requests for Oral Presentations: Registration is not required to attend the meeting. Requests to make an oral presentation at the meeting must be submitted by April 17, 2007, to the contact person. Your request to make a presentation should include the following information: Name, title, firm name, address, telephone, fax number, and e-mail address. We will try to accommodate all persons who wish to make a presentation. The time allotted for E:\FR\FM\13MRN1.SGM 13MRN1

Agencies

[Federal Register Volume 72, Number 48 (Tuesday, March 13, 2007)]
[Notices]
[Pages 11368-11369]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-4450]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. 2007N-0073]


Agency Information Collection Activities; Proposed Collection; 
Comment Request; Control of Communicable Diseases; Restrictions on 
African Rodents, Prairie Dogs, and Certain Other Animals

AGENCY:  Food and Drug Administration, HHS.

ACTION:  Notice.

-----------------------------------------------------------------------

SUMMARY:  The Food and Drug Administration (FDA) is announcing an 
opportunity for public comment on the proposed collection of certain 
information by the agency. Under the Paperwork Reduction Act of 1995 
(the PRA), Federal agencies are required to publish notice in the 
Federal Register concerning each proposed collection of information, 
including each proposed extension of an existing collection of 
information, and to allow 60 days for public comment in response to the 
notice. This notice solicits comments on the information collection 
requirements establishing restrictions on the import, capture, 
transport, sale, barter, exchange, distribution, and release of African 
rodents, prairie dogs, and certain other animals.

DATES:  Submit written or electronic comments on the collection of 
information by May 14, 2007.

ADDRESSES:  Submit electronic comments on the collection of information 
to: https://www.fda.gov/dockets/ecomments. Submit written comments on 
the collection of information to the Division of Dockets Management 
(HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, 
Rockville, MD 20852. All comments should be identified with the docket 
number found in brackets in the heading of this document.

FOR FURTHER INFORMATION CONTACT: Jonna Capezzuto, Office of the Chief 
Information Officer (HFA-250), Food and Drug Administration, 5600 
Fishers Lane, Rockville, MD 20857,301-827-4659.

SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501-3520), Federal 
agencies must obtain approval from the Office of Management and Budget 
(OMB) for each collection of information they conduct or sponsor. 
``Collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR 
1320.3(c) and includes agency requests or requirements that members of 
the public submit reports, keep records, or provide information to a 
third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A)) 
requires Federal agencies to provide a 60-day notice in the Federal 
Register concerning each proposed collection of information, including 
each proposed extension of an existing collection of information, 
before submitting the collection to OMB for approval. To comply with 
this requirement, FDA is publishing notice of the proposed collection 
of information set forth in this document.
    With respect to the following collection of information, FDA 
invites comments on these topics: (1) Whether the proposed collection 
of information is necessary for the proper performance of FDA's 
functions, including whether the information will have practical 
utility; (2) the accuracy of FDA's estimate of the burden of the 
proposed collection of information, including the validity of the 
methodology and assumptions used; (3) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (4) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques, when 
appropriate, and other forms of information technology.

Control of Communicable Diseases; African Rodents and Other Animals 
That May Carry the Monkeypox Virus--21 CFR 1240.63 (OMB Control Number 
0910-0519)--Extension

    Under 21 CFR 1240.63(a)(2)(ii), an individual must submit a written 
request to seek permission to capture, offer to capture, transport, 
offer to transport, sell, barter, or exchange, offer to sell, barter, 
or exchange, distribute, offer to distribute, and/or release into the 
environment any of the following animals:
     Prairie dogs (Cynomys sp.),
     African Tree squirrels (Heliosciurus sp.),
     Rope squirrels (Funisciurus sp.),
     African Dormice (Graphiurus sp.),
     Gambian giant pouched rats (Cricetomys sp.),
     Brush-tailed porcupines (Atherurus sp.),
     Striped mice (Hybomys sp.), or
     Any other animal so prohibited by order of the 
Commissioner of Food and Drugs (the Commissioner) because of that 
animal's potential to transmit the monkeypox virus.
    The request cannot seek written permission to sell, barter, or 
exchange, or offer to sell, barter, or exchange, as a pet, the animals 
listed previously or any animal covered by an order by the 
Commissioner.
    The request must state the reasons why an exemption is needed, 
describe the animals involved, and explain why an exemption will not 
result in the spread of monkeypox within the United States.
     Our estimates are based on our current experience with the interim 
final rule. To estimate the number of respondents, we examined the 
number of requests we have received in fiscal year 2006. There were 122 
requests, submitted by 65 individuals, in that time, and this figure 
represents a minor increase over the previous estimate of 120 annual 
responses. (See 69 FR 7752 (February 19, 2004).) As we cannot determine 
whether the latest data indicates a trend towards more requests or is 
an anomaly, we have elected to increase our estimate to 122 requests. 
We also have revised the estimated number of respondents to 65 
(compared to 120 in our previous estimate) and, as a result, adjusted 
the annual frequency per response to 1.88 (which represents 122 
responses/65 respondents; the actual result is 1.8769, which we have 
rounded up to 1.88).
    Furthermore, consistent with our earlier Paperwork Reduction Act 
submission, we will estimate that each respondent will need 4 hours to 
complete its request for an exemption. Therefore, the total reporting 
burden under 21 CFR 1240.63(a)(2)(ii)(A) and (B) will be 488 hours (122 
responses x 4 hours per response = 488 hours).
    FDA estimates the burden of this collection of information as 
follows:

[[Page 11369]]



                                      Estimated Annual Reporting Burden\1\
----------------------------------------------------------------------------------------------------------------
                         No. of        Annual Frequency     Total No. of        Hours per
  21 CFR Section      Respondents        per Response        Responses           Response         Total Hours
----------------------------------------------------------------------------------------------------------------
1240.63(a)(2)(ii)                 65               1.88                122                  4                488
 (A) and (B)
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
  information.


    Dated: March 6, 2007.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E7-4450 Filed 3-12-07; 8:45 am]
BILLING CODE 4160-01-S
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.